BMS strengthens clinical partnership with Icon
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb has chosen the Dublin-based CRO Icon as a preferred partner for its early phase clinical development programmes, furthering the agreement it made with the CRO in June 2010.